ARTICLE | Company News
InterMune, MoliChem in pulmonary deal
May 11, 2001 7:00 AM UTC
The companies will jointly develop and market MLCM's Moli1901 duramycin pulmonary compound worldwide. MLCM will receive a $1.5 million upfront payment plus milestones. ITMN and MLCM will share equally...